Hemangioma Clinical Trial
Official title:
Diode Laser 980-nm in Hemangioma Treatment
In an academic, government clinic, uni-center, randomized within patients trial study of the
effects of 980-nm diode laser treatment included 15 cases of facial hemangiomas in patients
with a history of discomfort due to lesions that were not suitable for removal using
traditional methods. The study was carried out at the University of Baghdad/Institute of
Laser for Postgraduate Studies/Laser Medicine Research Clinics from 15 October 2018 to 15
April 2019. Primary end-point is improvement of conditions at 6 months. Secondary end-points
are quality of life, disappear lesions and safety administration of diode laser. Each patient
received 12 sessions at two-week intervals. Lesions were photographed before and after laser
treatment and digital image histograms were generated as a graphical representation of the
tonal distribution.
Following treatment, the lesions were less elevated, smoother in texture, and the color
changed from dark red to light pink.
There is a need to improve the treatment of face hemangiomas. Results from this randomized
within patient trial will serve as preliminary evidence of the future role of diode laser in
hemangioma treatment and a basis for design and power estimations of future studies. Based on
the skin texture, color and elevation of the hemangioma as well as patient satisfaction, this
type of laser is a safe and effective modality for the treatment of facial hemangioma in
Iraqi patients.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01685398 -
Topical Timolol for Superficial Infantile Hemangioma
|
Phase 3 | |
| Withdrawn |
NCT00974129 -
A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas
|
N/A | |
| Completed |
NCT00374335 -
Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas
|
N/A | |
| Recruiting |
NCT03331744 -
Clinical Characteristics of Infantile Hemangioma
|
||
| Completed |
NCT02342275 -
Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma
|
Phase 3 | |
| Completed |
NCT00433940 -
Immune Suppression Of Infants Treated With Steroids
|
N/A | |
| Terminated |
NCT01743885 -
Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma
|
Phase 3 | |
| Terminated |
NCT00555464 -
Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas
|
Phase 2 | |
| Completed |
NCT00394888 -
Hemangioma Associated With High Rates of Morbidity
|
N/A | |
| Completed |
NCT05327309 -
Role of Propranolol as Compared to Bleomycin in Management of Hemangioma
|
N/A | |
| Completed |
NCT02145884 -
Topical Timolol Gel for the Treatment of Infantile Hemangiomas
|
Phase 2 | |
| Completed |
NCT04077515 -
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
|
Phase 4 | |
| Completed |
NCT02731287 -
Topical Timolol for Infantile Hemangioma in Early Proliferative Phase
|
Phase 2 | |
| Recruiting |
NCT01147601 -
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
|
Phase 0 | |
| Completed |
NCT01908972 -
The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma
|
Phase 4 | |
| Completed |
NCT00540566 -
Optical Biopsy of Human Skin in Conjunction With Laser Treatment
|
||
| Completed |
NCT00001417 -
Direct Injection of Alcohol for the Treatment of Spinal Tumors
|
N/A | |
| Completed |
NCT00004436 -
Randomized Study of Hormonal Regulation of Infantile Hemangioma
|
N/A | |
| Recruiting |
NCT02496013 -
Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
|
Phase 1 | |
| Completed |
NCT01072045 -
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
|
Phase 2 |